The handling and storage guidance below reflects standard practice in published peptide research literature
In the long-term toxicity experiment, continuous injection of AOD 9604 (10 mg/kg) for 8 weeks did not cause abnormal liver and kidney functions or fluctuations in blood glucose, providing a safety basis for its further research and application
Research shows that 20% to 50% of these patients might not have enough B12
Example (for a 10mg vial reconstituted in 2 mL of BAC water): Total peptide: 10mg BAC water added: 2 mL Resulting concentration: ~5 mg/mL Recommended practice: Use sterile bacteriostatic water (0.9% benzyl alcohol) for reconstitution
3 4 Indications for B 12 treatment, administration routes, and preparations Treatment with B 12 may be required for a variety of reasons (table 1)
Advanced considerations For researchers with experience in metabolic optimization, several advanced considerations may be relevant